Redeye comments on SciBase’s rights issue. The announcement came as no surprise, as we had already incorporated an equity raise into our model for the quarter. We update our model accordingly and also include a further capital injection in 2027e, which we expect to provide the funding required to reach profitability. The changes result in increased dilution and a lower Base Case, although we continue to see solid upside potential in the share.
LÄS MER
